biosimilars

Tufts: biosimilars will not be an instant hit
Medical Marketing and Media
Thu, 03/5/15 - 06:34 pm
biosimilars
Merck touts a bright future in biosimilars with a stable of would-be blockbusters
Fierce Biotech
Wed, 03/4/15 - 09:51 am
Merck
biosimilars
AbbVie
Humira
JNJ
Remicade
Amgen
Enbrel
Samsung Bioepis
Biogen Idec
Is This Amgen's Next Big Thing?
Investopedia
Tue, 03/3/15 - 07:55 am
Amgen
evolocumab
biosimilars
Novartis AG, Amgen, Inc. Tussle Over Neupogen Biosimilar Continues
Bidness Etc.
Sun, 03/1/15 - 11:40 am
Novartis
Amgen
biosimilars
Neupogen
FDA postpones key hearing on biosimilar copy of blockbuster drug
Yahoo/Reuters
Thu, 02/26/15 - 09:55 am
FDA
biosimilars
Rensima
Remicade
JNJ
rheumatoid arthritis
Crohn's Disease
Hospira
Celltrion
Celltrion, Hospira avoid biosimilar traffic jam in U.S.
BioCentury
Tue, 02/24/15 - 10:36 am
Celltrion
Hospira
biosimilars
Remicade
Lilly peglispro delay may be boon for its biosimilar
Medical Marketing and Media
Mon, 02/23/15 - 05:54 pm
Eli Lilly
Peglispro
diabetes
basal insulin
biosimilars
Sanofi
Lantus
If Pfizer's Right, Hospira Biosimilar Gold Rush Begins This Week
Forbes
Mon, 02/16/15 - 11:55 am
Pfizer
Hospira
M&A
biosimilars
Inflectra
Europe
autoimmune disease
Hospira–Pfizer merger: Benefits from growing biosimilars market
Yahoo/Market Realist
Thu, 02/12/15 - 09:07 am
Hospira
Pfizer
M&A
biosimilars
Competition to J&J's Remicade looms in U.S. as biosimilar conquers new markets
Fierce Biotech
Wed, 02/11/15 - 08:57 am
JNJ
Remicade
biosimilars
FDA
Celltrion
Remsima
Amgen, Inc. Files Petition To Stop Novartis (NVS) From Launching Neupogen Bilosimilar
Bidness Etc.
Tue, 02/10/15 - 08:38 am
Amgen
Novartis
Neupogen
biosimilars
Pfizer Inc. GEP Unit To Become Largest Biosimilar And Generic Drugs Developer
Bidness Etc.
Mon, 02/9/15 - 10:34 am
Pfizer
biosimilars
generics
Hospira
M&A
Sandoz gets ready to make the biosimilar case with oncologists
Medical Marketing and Media
Thu, 01/22/15 - 09:51 am
Sandoz
biosimilars
physicians
oncologists
Neupogen
Zarxio
Novartis
'Biosimilars' law returns to Colorado Legislature; would allow generics to be swapped for biotech drugs
Bizjournals.com
Mon, 01/19/15 - 10:12 am
biosimilars
Colorado
What the FDA Panel Vote on a Biosimilar Says About Approvals
WSJ Pharmalot
Thu, 01/8/15 - 04:28 pm
FDA
advisory panels
biosimilars
FDA panel recommends approval for first generic biotech drug
Marketwatch
Wed, 01/7/15 - 06:49 pm
FDA
advisory panels
biosimilars
Neupogen
Amgen
Novartis
Sandoz
Biosimilars Come To The US: Should AbbVie (ABBV) Be Worried?
Bidness Etc.
Tue, 01/6/15 - 03:51 pm
AbbVie
biosimilars
Humira
FDA staff recommends Novartis copy of Amgen's Neupogen
Yahoo/Reuters
Mon, 01/5/15 - 09:29 am
FDA
Amgen
Novartis
Neupogen
biosimilars
breast cancer
Zarzio
chemotheraphy-induced neutropenia
Could the World's Top-Selling Drug Be Toppled?
Motley Fool
Mon, 12/15/14 - 09:03 am
AbbVie
Humira
Cadila
biosimilars
Sovaldi
Harvoni
Gilead Sciences
India's Cadila launches first cheaper copy of world's top-selling drug
Yahoo/Reuters
Tue, 12/9/14 - 07:51 am
India
Cadila
AbbVie
Humira
biosimilars

Pages